Simms Christopher Paul 4
4 · IVERIC bio, Inc. · Filed Dec 22, 2022
Insider Transaction Report
Form 4
IVERIC bio, Inc.ISEE
Simms Christopher Paul
SVP, Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-12-20+75,000→ 75,000 totalExercise: $22.57Exp: 2032-12-20→ Common Stock (75,000 underlying) - Award
Restricted Stock Units
2022-12-20+37,500→ 37,500 total→ Common Stock (37,500 underlying)
Footnotes (3)
- [F1]Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the stock option award will vest with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares, in approximately equal monthly installments through the fourth anniversary of the grant date.
- [F2]Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
- [F3]Subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of restricted stock units will vest with respect to 25% of the shares subject to the award in annual installments (on January 2, 2024, January 2, 2025, January 2, 2026 and January 2, 2027).